CPRX vs. QQQ

In the year-to-date period, CPRX achieves a 16.77% return, which is significantly higher than QQQ's 2.16% return. Over the past 10 years, CPRX has outperformed QQQ with an annualized return of 19.87%, while QQQ has yielded a comparatively lower 17.81% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CPRX Sharpe Ratio is 1.19, which is higher than the QQQ Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of CPRX and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CPRX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.57%.

The maximum CPRX drawdown since its inception was -94.25%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for CPRX and QQQ. For additional features, visit the drawdowns tool.

Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 10.00% compared to Invesco QQQ (QQQ) at 6.50%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.